As of Q4'25 (2025-11-02), AVGO reported R&D Expenses of USD 2.98B and SG&A Expenses of USD 1.11B. This marks the highest R&D spending in the period, with SG&A remaining relatively stable compared to recent quarters. From Q1'23 to Q4'25, both R&D and SG&A expenses show a significant upward trend, particularly with a sharp increase in Q1'24, where R&D jumped from USD 1.39B to USD 2.31B and SG&A surged from USD 418M to USD 1.57B. After this spike, R&D expenses continued to climb, peaking at USD 3.05B in Q3'25 before a slight pullback, while SG&A expenses stabilized around the USD 1.1B mark. The overall trend reflects substantial growth in operating expenses over the observed period, with notable volatility in early 2024.